▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | GreenCity | Italian Channel Awards | Italian Project Awards | ...

Autoimmune Disease Diagnostics Market Research, Size, Global Forecasts 2024-2030: Robotics and AI, Autoantibody Assays and Genetic Testing, & Innovative Biomarkers Drive Expansion - ResearchAndMarkets.com

The "Autoimmune Disease Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ResearchAndMarkets...

Business Wire

DUBLIN: The "Autoimmune Disease Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Global Autoimmune Diseases Diagnostics Market is projected to be valued at around US$ 8.64 Billion by 2030 from US$ 5.32 Billion in 2023, growing at a CAGR of 7.17% between 2024 and 2030.

The growing old global population, specifically susceptible to autoimmune illnesses, fuels a growing diagnostics market. This demographic shift opens a new and expanding phase for diagnostics, contributing to a heightened market boom. The market studies a banquet of new biomarkers and tests for rarer autoimmune diseases, catering to numerous patients' needs.

The market is increasing with rising healthcare spending, propelled by improved public and private funding globally. Expanded insurance coverage, in addition, complements accessibility to diagnostics, making these tests available to a broader population. This combination creates a flourishing market environment with various services and financial support.

Surging cognizance prompts early consultations for autoimmune illnesses, propelling the demand for specialized diagnostics and personalized treatment plans. Leveraging autoantibody assays, genetic testing, imaging, and diagnostics offers particular results. Robots streamline labs, while point-of-care testing complements accessibility.

AI accurately predicts sickness dangers, promising a vibrant future for customized treatments. In the United States, the autoimmune disease diagnostics market is projected to develop appreciably because of new product introductions and the presence of primary companies. These elements contribute to the market's dominance and expected increase throughout the forecast period.

Diagnostics Equipment has a solid claim to the leading position in the global autoimmune diseases diagnostics market

By product, the global autoimmune diseases diagnostics market is fragmented into Therapeutic & Monitoring Equipment, Diagnostics Equipment, and Drugs. An accurate and well-timed prognosis is vital in dealing with autoimmune diseases. Diagnostics Equipment, from blood analyzers to imaging systems, identifies situations early, improving effects.

With a vast variety of tests, such as specialized imaging, it caters to various needs. Technological advancements, like AI and automation, drive growth. Rising occurrence fuels demand for supporting innovation. Personalized treatment is based on correct analysis. Supportive regulations and insurance coverage enhance accessibility. Streamlined workflows and automation lessen mistakes. Early intervention ability promises disease prevention.

Systemic autoimmune diseases (SADs) hold a significant portion of the global autoimmune diseases diagnostics market

The global autoimmune diseases diagnostics market is segmented into Systemic Autoimmune Disease Diagnostics and Localized Autoimmune Disease Diagnostics. Systemic autoimmune diseases (SADs) impose considerable morbidity and mortality, often necessitating lifelong treatment and monitoring, hence driving demand for specialized diagnostics.

Notable improvements, including noticeably precise autoantibody assays, genetic testing for susceptibility markers, and advanced imaging strategies, enhance diagnostics accuracy and efficiency, bolstering market growth. Early detection is pivotal in coping with SADs efficaciously, lowering disease development and organ damage, thereby fostering demand for reachable and precise diagnostics tools. With elevated consciousness of SADs and their effects, individuals are proactively in search of medical interest and screening tests, in addition to stimulating market enlargement.

Rheumatic disease diagnostics occupy a substantial share in the autoimmune diseases diagnostics market

By indication, the global autoimmune diseases diagnostics market is categorized into Rheumatic Disease, Diabetes, Multiple Sclerosis, Inflammatory Bowel Disease, and Others. Rheumatic diseases, affecting 1 in 4 adults globally, fuel tremendous demand for diagnostics. Diverse subtypes like rheumatoid arthritis and lupus require precise diagnostics techniques, propelling the improvement of a vast range of tests.

Diagnosis complexity, with overlapping signs, mandates advanced strategies like autoantibody assays and genetic testing. Early detection is essential for capable management and decreasing joint damage. Research emphasizes novel diagnostics Equipment, enhancing accuracy and permitting personalized medicine. This shift towards tailor-made remedies underscores the significance of correct diagnostics in predicting disorder development and guiding interventions.

Diagnostics centers are expected to hold a significant share in the global autoimmune diseases diagnostics market

By end-users, the global autoimmune diseases diagnostics market is divided into Hospitals, Diagnostics Centers, and Others. Specialized diagnostics centers excel in autoimmune disease, testing with targeted expertise, and providing quicker, correct diagnoses using cutting-edge technology. They prioritize patient satisfaction because they are cost-effective, easily located, and aligned with value-based care.

Collaboration with primary care physicians streamlines referrals, ensuring suitable testing is done. Integrated digital structures enhance efficiency. Amidst the surge in outpatient services, diagnostics facilities become pivotal in autoimmune disease diagnosis and control, playing a valuable function in the evolving healthcare panorama.

Asia-Pacific is undoubtedly a key player in the global autoimmune diseases diagnostics market, and its potential for continued expansion is significant

Asia-Pacific, home to over half the worldwide population, faces a rising burden of autoimmune diseases. According to the Arthritis Foundation of Asia, about 47 percent of diabetes and 49 percent of heart patients are diagnosed with arthritis. The region's adoption of cost-effective diagnostics solutions and growing disposable earnings expand access to diagnostics, propelling market increase. Strategic initiatives, like Avesthagen Limited's alliance with Wipro Limited in June 2022 to commercialize genetic testing in India, similarly make contributions. Partnerships like these are expected to strengthen market expansion in the place.

Company Analysis: Overview, Recent Developments, Revenue Analysis

  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Roche Diagnostics
  • Siemens Healthineers
  • Bio Merieux SA
  • Myriad Genetics, Inc.
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific Inc.

Scope of the Report

Product - Global Autoimmune Diseases Diagnostics Market breakup in 3 viewpoints:

  • Therapeutic & Monitoring Equipment
  • Diagnostics Equipment
  • Drugs

Types - Global Autoimmune Diseases Diagnostics Market breakup in 2 viewpoints:

  • Systemic Autoimmune Disease Diagnostics
  • Localized Autoimmune Disease Diagnostics

Indication - Global Autoimmune Diseases Diagnostics Market breakup in 5 viewpoints:

  • Rheumatic Disease
  • Diabetes
  • Multiple Sclerosis
  • Inflammatory Bowel Disease
  • Others

End-Users - Global Autoimmune Diseases Diagnostics Market breakup in 3 viewpoints:

  • Hospitals
  • Diagnostics Centers
  • Others

Countries - Global Autoimmune Diseases Diagnostics Market of 25 Countries

  • North America
  • United States
  • Canada
  • Europe
  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Belgium
  • Netherlands
  • Turkey
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Thailand
  • Malaysia
  • Indonesia
  • Australia
  • New Zealand
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa

For more information about this report visit https://www.researchandmarkets.com/r/8gguqj

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

Gyala: a new "Made in Italy" cybersecurity

With a proven track record in the defence field, Gyala now also brings its cybersecurity technologies to the wider enterprise audience

ITALIAN PROJECT AWARDS 2023: the best IT projects of the year, awarded

Now in its third edition, the initiative is targeted at the ICT professional world and honours projects based on innovative ideas and technologies, realised…

I3P launches the Cybersecurity Incubation Program

The I3P's initiative is promoted together with the National Cybersecurity Agency in collaboration with Leonardo and C*Sparks.

iVis Technologies enables remotely-controlled corneal telesurgery

It's based on Italian technologies the first successful intercontinental telesurgery intervention for keratoconus carried out remotely, connecting Bari…

Most read

Argentina Prepaid Card and Digital Wallet Business Report 2024: Market…

The "Argentina Prepaid Card and Digital Wallet Business and Investment Opportunities Databook - Market Size and Forecast, Consumer Attitude & Behaviour,…

MDS Property Management Software Achieves SOC 2 Compliance

#newyorkcity--MDS Property Management Software is pleased to announce the successful completion of its System and Organization Controls (SOC) 2 audit,…

University of Phoenix Leadership Joins Proceedings of 2024 PESC-A4L Spring…

University of Phoenix is pleased to share that Vice Provost of Strategy, Marc Booker, Ph.D., Senior Director of Program Deployment; Hillary Halpern, M.B.A.;…

Ault Alliance Declares Monthly Cash Dividend of $0.2708333 Per Share of…

$AGREE #13_Percent_Cumulative_Preferred--Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company (“Ault Alliance,” or the “Company”),…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!